Mosaic hepatitis B virus core particles allow insertion of extended foreign protein segments

J Gen Virol. 1997 Aug:78 ( Pt 8):2049-53. doi: 10.1099/0022-1317-78-8-2049.

Abstract

Because of its particular immunological properties, the core protein of hepatitis B virus (HBcAg) has become one of the favoured 'virus-like particles' for use as a carrier of foreign epitopes. A new strategy to construct core particles presenting extended foreign protein segments was established based on the introduction of a linker containing a translational stop codon between sequences encoding a C-terminally truncated HBcAg (HBcAg delta) and a foreign protein sequence. Expression in an Escherichia coli suppressor strain allowed the simultaneous synthesis of both HBcAg delta and a read-through fusion protein containing a part of the hantavirus nucleocapsid protein. After purification, the presence of core-like mosaic particles with HBc and hantavirus antigenicity was demonstrated by electron microscopy and immunological tests. This strategy of partial stop codon suppression should improve the use of HBcAg as a carrier of foreign epitopes by allowing insertion of long foreign sequences into particle-forming proteins. The resulting mosaic particles should be of general interest for further vaccine developments.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Base Sequence
  • Cloning, Molecular / methods*
  • Drug Design
  • Escherichia coli
  • Hepatitis B Core Antigens / biosynthesis*
  • Hepatitis B Core Antigens / ultrastructure
  • Hepatitis B virus / genetics*
  • Microscopy, Electron
  • Mosaicism
  • Mutagenesis, Insertional / methods*
  • Nucleocapsid / biosynthesis*
  • Nucleocapsid / ultrastructure
  • Orthohantavirus / genetics*
  • Plasmids
  • Recombinant Fusion Proteins / biosynthesis*
  • Recombinant Fusion Proteins / ultrastructure
  • Sequence Deletion
  • Vaccines, Synthetic
  • Viral Vaccines

Substances

  • Hepatitis B Core Antigens
  • Recombinant Fusion Proteins
  • Vaccines, Synthetic
  • Viral Vaccines